Palvella Therapeutics Inc Ne

PVLANASDAQ · US

Holders

REDUCEDT+2
Goin Kathleen
Palvella Therapeutics Inc Ne · NASDAQ
−400 sh · $61.2K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Goin Kathleen
Palvella Therapeutics Inc Ne · NASDAQ
−1,998 sh · $303.3K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Goin Kathleen
Palvella Therapeutics Inc Ne · NASDAQ
−302 sh · $47.3K
Filed 20 Aug 2026SEC Form 4view source
ACQUIREDT+2
Goin Kathleen
Palvella Therapeutics Inc Ne · NASDAQ
+2,154 sh · $15.4K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Goin Kathleen
Palvella Therapeutics Inc Ne · NASDAQ
−1,500 sh · $227.1K
Filed 20 Aug 2026SEC Form 4view source
ACQUIREDT+2
Goin Kathleen
Palvella Therapeutics Inc Ne · NASDAQ
+2,148 sh · $19.5K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Goin Kathleen
Palvella Therapeutics Inc Ne · NASDAQ
−102 sh · $15.9K
Filed 20 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Two Sigma Investments
Palvella Therapeutics Inc Ne · NASDAQ
4,890 sh · $609.5K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDQuarterly
Renaissance Technologies
Palvella Therapeutics Inc Ne · NASDAQ
17,970 sh · $2.2M
Filed 31 Mar 2026SEC 13Fview source